H ost-pathogen interactions begin with transmission and continue as the pathogen disseminates into deeper tissues. These tissues are in themselves microenvironments with defined immunological characteristics and can serve as barriers to prevent spread. For arthropod-borne pathogens, the skin epithelium is the first barrier that must be surpassed to penetrate into deeper organs (1, 2). The complexity of the immune responses of each layer of the skin reflects the specificity at which this tissue can act upon invaders.
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Based on its histological architecture, the skin can be divided into three main layers, namely, epidermis, dermis, and subcutaneous space (also known as hypodermis) (3) . Each layer encompasses not only specific architectural qualities but also unique immunological characteristics that define them (2) . How these characteristics influence the progression of infection is unknown. The epidermis is the outermost layer of the skin and constitutes a strong physical barrier that pathogens must cross to enter the body. Pathogens that survive in bloodfeeding arthropods can cross this layer through the mechanical action of the arthropod's probing mouth parts (4) . Consequently, the dermis, located immediately adjacent to the epidermis, is highly exposed to these pathogens. Because most arthropod vectors do not penetrate beyond the dermis to the subcutaneous (s.c.) space, the dermis is, most likely, the first tissue where initial host-pathogen interactions occur during vector-borne infections (1, (5) (6) (7) .
Yersinia pestis is a Gram-negative bacterium and the causative agent of plague. This highly virulent pathogen was responsible for major pandemics in history and continues to survive in animal reservoirs in many parts of the world (8, 9) . Bubonic plague is the most prevalent form of the disease and occurs after bacterial inoculation into the skin, typically by a flea vector (10) . From the skin, Y. pestis disseminates to draining lymph nodes (LNs) via lymphatic vessels (11) and then to deeper organs through the bloodstream (12) . Systemic dissemination results in septic shock, severe organ failure, and death.
Models of infection that target the s.c. space are broadly used in plague research (13) (14) (15) (16) as this is a relatively easy tissue to target. However, the dermis is strongly implicated as the layer of the skin probed by fleas during transmission (5, 17) . In comparison with s.c. models, intradermal (i.d.) inoculations require more dexterity and can be more challenging to implement in biosafety level three facilities, which are mandatory when handling fully virulent strains of Y. pestis. In this study, we further characterize the i.d. model we used in a previous study (11) and compare i.d. and s.c. inoculations to investigate whether infection model impacts progression of bubonic plague. We found substantial differences in disease progression after inoculation by the two different routes. In addition, we found that dissemination of bacteria from the LNs is restricted. These findings are relevant for the understanding of Y. pestis dissemination and pathogenesis and of host responses to different inoculation routes. Moreover, our study emphasizes the importance of using a biologically relevant model when studying host-pathogen interactions in vivo.
MATERIALS AND METHODS
Bacterial cultures. Fully virulent Y. pestis CO92 was used in all the experiments of this study (18, 19) . Bacteria were streaked on brain heart infusion (BHI; BD Biosciences, Bedford MA) agar plates from frozen stocks and incubated at 26°C for 48 h. Liquid cultures in BHI broth were incubated for 15 h at 26°C with aeration. The ⌬rovA strain was constructed by allelic exchange, as described elsewhere (20) . The ⌬psaA strain was constructed using the Red recombination system, as described elsewhere (20, 21) . The procedures employed to construct the isogenic set of 10 tagged strains used in the dissemination assays were previously described (11, 22) . These 10 Y. pestis tagged strains have growth and virulence characteristics similar to those of untagged bacteria (11) . For the dose-dependent survival assays (DDSA), an untagged wild-type (WT) strain was used.
Animal inoculations. Female C57BL/6J mice (6 to 8 weeks old; Jackson Laboratory, Bar Harbor, ME) were inoculated with Y. pestis after injection of a ketamine-xylazine mix. Intradermal (i.d.) inoculations were performed as previously described (11) . Briefly, ϳ200 CFU in 2 l was injected into the dorsal leaflet of the ear pinna with the aid of a Pump11 Elite syringe pump (Harvard Apparatus, Holliston, MA). The same procedure was used for the subcutaneous (s.c.) inoculations except that mice were injected in the ventral cervical region. Organs were harvested at different time points, homogenized, diluted, and plated on BHI agar to enumerate the bacteria in each organ. For the i.d. and s.c. inoculations, the superficial parotid LNs and the superficial cervical LNs, respectively, were harvested (23) .
For the assay to determine the presence of a bottleneck, 9 of the 10 tagged strains were grown in BHI broth with 25 g/ml kanamycin. The cultures were then mixed (equal optical density at 600 nm [OD 600 ] for each culture) and used to inoculate mice as previously described (11). For both routes (i.d. and s.c.), ϳ200 CFU of the mix was inoculated (ϳ22 CFU of each of the nine tagged strains). The 10th tagged strain was omitted from the mix so it could be used as a negative control. Bacteria recovered from tissues were used for DNA extraction, this DNA was then used as a probe for Southern dot blot analysis, and results from the blots were scored as previously described (11) . Statistical analysis was performed using a Mann-Whitney or Wilcoxon matched-pairs signed-rank test calculated by GraphPad Prism version 4.0c for Macintosh (GraphPad Software, La Jolla, CA). We established statistical significance at a P of Ͻ0.05.
This study was carried out in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (24) . All animal studies were approved by the Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill (protocol 11-128). All efforts were made to minimize suffering; animals were monitored every 12 h following inoculation and were euthanized upon exhibiting signs of morbidity.
RESULTS
Y. pestis does not proliferate in the skin. We previously used a murine i.d. model of infection in which the inoculum (ϳ200 CFU) was injected in the dermis of the ear pinna (11) . Because of the absence of subcutaneous tissue in the ear, this model results in i.d., as opposed to s.c., inoculation (25) . A key attribute of our model is the use of a 2-l inoculation volume, which contrasts with the 10-l volume reported in previous studies using i.d. inoculation in the ear (25, 26) . We considered that in comparison with larger volumes, the 2-l model would mimic more closely the small volume that must be deposited by a flea during natural inoculations. In addition, the size of the injection wheal produced by a 10-l volume in the skin is much larger than that produced by a 2-l volume (Fig. 1A) ; we postulated that larger volumes could generate confounding effects due to tissue disruption. Thus, we established 2 l as a preferred volume of inoculation. With this model, we noted that bacterial loads in the skin do not change significantly over time except when mice are subjected to neutrophil depletion (11) . Because it has been reported that bacterial loads increase in the skin during Y. pestis infections (25, 26) , we revisited our model to consider possible explanations for this discrepancy. Thus, we asked whether the inoculation volume affects bacterial proliferation in the skin. We compared bacterial loads in the skin after injection of the same bacterial dose using either 2 or 10 l as the inoculation volume at a time point that precedes systemic dissemination (24 h postinoculation [hpi]). We found a small but significant increase in the number of CFU in the skin of mice injected with 10 l in comparison with that in mice injected with 2 l (Fig. 1B) . This indicates that larger volumes of inoculation favor bacterial proliferation in the skin.
We also considered the possibility that the reported increase in bacterial numbers in the skin derives from measurements taken when the bacteria are circulating systemically (time points after 24 hpi). To test this, we inoculated mice in the right ear, and at 48 hpi, we determined the bacterial burdens in the left and right ears. The number of bacteria in the inoculated ear (right ear) was significantly larger than the ϳ200 CFU that was inoculated, which could Spleens of these animals were negative (i.e., systemic spread had not occurred). Differences between groups were determined by a Mann-Whitney test, and the obtained P value is shown. (C) Numbers of CFU in right and left ears harvested at 48 hpi. Only the right ear was inoculated. Ears (left and right) represented with the same symbol (circle, triangle, or square) and color (black, gray, or white) belong to the same mouse, so a direct comparison between the inoculated and noninoculated ears can be appreciated. The horizontal lines depict the median value of a group. All values are over the limit of detection (dotted line). Differences between groups were determined by a Wilcoxon matchedpairs signed-rank test. For panels B and C, significance was established at a P of Ͻ0.05. Each symbol represents the number of CFU obtained from a tissue, and the dotted line shows the limit of detection. Data from two combined independent experiments are shown. be interpreted as Y. pestis proliferating in the skin. However, the bacterial loads in this ear were comparable to those in the uninoculated ear (left ear) (Fig. 1C) . This suggests that large numbers of bacteria in the skin at later stages of infection derive from bacteria circulating systemically and not necessarily from net bacterial proliferation in this tissue. Of note, it is possible that inoculations with very high doses (Ͼ2,000 CFU) affect neutrophil activity (11) and result in bacterial proliferation. However, we think that these events are not relevant, as flea inoculations rarely result in high bacterial doses in the skin. Thus, overall, our data suggest that Y. pestis does not proliferate significantly in the dermis of the skin.
Intradermal inoculations result in faster kinetics but lower mortality rates than s.c. inoculations. We recently reported the presence of a bottleneck during i.d. inoculations and that the bottleneck was not observed when the bacteria were injected s.c. (11) . With this important difference between the i.d. and s.c. models, we hypothesized that inoculations into these different layers of the skin could affect disease progression. To test this, mice were inoculated i.d. (ear, harvesting the parotid LN) or s.c. (scruff of the neck, harvesting the cervical LN), and bacterial loads in draining LNs and spleens at 48 hpi were determined ( Fig. 2A) . The median number of bacteria in LNs of mice inoculated i.d. was ϳ100-fold higher than the median value in LNs of mice inoculated s.c. This difference was determined to be statistically significant (MannWhitney test, P ϭ 0.0002). Bacterial burdens in the spleen, an organ used to assess systemic dissemination, showed an even larger difference between groups. The median number of bacteria in spleens from mice inoculated i.d. was ϳ10 6 -fold higher than in mice inoculated s.c. Faster kinetics of dissemination after i.d. injections do not derive from the anatomical localization of the draining LN, as the site of inoculation in the ear is considerably more distant to its draining LN than the site of inoculation in the neck, which is adjacent to the cervical draining LNs. These data indicate that the route of inoculation affects the kinetics of infection.
We had noted that when mice were inoculated i.d. with our normal dose (ϳ200 CFU), approximately 1/10 of the animals did not have bacteria in the LNs (data not shown). These mice had the expected numbers of bacteria in the ear, confirming that they were inoculated properly. This suggests that the inoculation route could also impact mouse survival. A dose-dependent survival assay (DDSA) was used to determine differences in survival times for each of the inoculation routes. A DDSA can also reveal how these differences are influenced by the dose (number of CFU in the inocula). Mice were inoculated i.d. with a low (ϳ7-CFU), medium (ϳ71-CFU), or high (ϳ710-CFU) dose, and survival was monitored during the following 14 days. Inoculation with the low dose resulted in 67% mouse survival (Fig. 2B) . Survival rates of mice inoculated with the medium and high doses were 25% and 0%, respectively. For the whole group, death was first observed at day 2. Most mice died between days 2 and 4, with the exception of one mouse from the low-dose group, which died on day 11. For the group inoculated s.c., the doses used were ϳ24 CFU, ϳ240 CFU, and ϳ2,400 CFU. Regardless of the dose, no mice inoculated s.c. survived (Fig. 2C) . With the exception of one mouse in the high-inoculum group that died at day 3.5, all mice died between days 4.5 and 7. These data indicate that mouse survival after i.d. inoculation, but not after s.c. inoculation, appeared to be linked to inoculum size.
A deletion mutant lacking a global regulator of Y. pestis is more attenuated after i.d. inoculation than after s.c. inoculation. We previously demonstrated that after s.c. inoculation, Y. pestis deletion mutants lacking the transcriptional regulator RovA or the putative antiphagocytic factor PsaA are attenuated (20, 27) . Microarray and reverse transcription-quantitative PCR (qRT-PCR) analyses revealed that expression of psaA was substantially decreased in the ⌬rovA strain. Because the degrees of attenuation of the two mutants were similar, we inferred that PsaA was the main (if not the only) virulence factor regulated by RovA during bubonic plague. Since we found important differences between our i.d. and s.c. models, we asked whether mutants characterized in the s.c. model would behave in the same way after i.d. inoculation. Thus, we tested the ⌬rovA and ⌬psaA strains in our i.d. model. We used time points relevant to the kinetics for this route (24 and 48 hpi), and in addition to LNs and spleens, we also harvested ears (site of inoculation). Both ⌬rovA and ⌬psaA strains were attenuated compared to WT Y. pestis (Fig. 3A, B, and C) . At 24 hpi, the two mutant strains showed similar levels of attenuation in the ears and LNs when compared to one another. However, in contrast to what was observed in the s.c. model, the ⌬rovA strain was significantly more attenuated than the ⌬psaA strain at 48 hpi (Fig. 3) . This difference was especially evident in LNs at 48 hpi (Fig. 3 B) , where the median value of bacterial counts of the ⌬rovA strain was at the limit of detection and the median number of CFU for the ⌬psaA strain was 6 logs higher. Significant differences between the two strains were also observed in ears and spleens, although this most likely reflects delays in systemic infection by the ⌬rovA strain that resulted from the lower levels of LN colonization by this mutant (Fig. 3A and C) . Overall, this indicates that after i.d. inoculation, Y. pestis lacking rovA is significantly more attenuated than Y. pestis lacking psaA. This finding differs from what was observed after s.c. inoculations, in which case both mutants were equally attenuated (20) .
An s.c. route of inoculation reveals a bottleneck in bacterial dissemination from LNs to deeper organs. Using oligonucleotide-tagged isogenic strains of Y. pestis, we previously identified a bottleneck during early stages of infection following i.d. inoculation (11); only a small fraction of the tagged strains that were inoculated i.d. into the skin were subsequently present in draining LNs. This suggested that the bottleneck affected bacterial dissemination from the skin to the LNs. We suspected that a second bottleneck existed in the dissemination of Y. pestis from the LNs to systemic sites, because in some instances a tagged strain that was present in the LNs was absent in the spleen. However, this was difficult to test because the number of tagged strains in the LNs after i.d. inoculations is very low. Thus, it is impossible to assess any further reduction in the numbers of tagged strains beyond the LNs. Notably, in the same study, we found that the bottleneck was almost completely abrogated when Y. pestis was inoculated s.c., as nearly all tagged strains were found in draining LNs (Fig. 4A) . Therefore, we used this model as a strategy to test whether Y. pestis passes through a bottleneck when disseminating from LNs to systemic circulation. We assumed that the route of inoculation affects only dissemination from the skin to the LNs and does not affect dissemination beyond this compartment. Mice were inoculated s.c. with nine tagged strains, and LNs and spleens were harvested at 72 hpi, a time point when the numbers of CFU in the spleens are close to maximal. Five out of six mice had fewer tagged strains in the spleens than in the LNs (Fig. 4B) . The number of tagged strains present in the LNs but absent in the spleens ranged from five to eight. Differences between the numbers of tagged strains in LNs and spleens were significant (Fig. 4C) . These data indicate that only a few of the tagged strains in the LNs predominate in a systemic organ (spleen).
DISCUSSION
Only in recent years have we begun to appreciate the significance of the differences between in vivo and in vitro approaches to studying host-pathogen interactions. This has resulted in the development of new animal models with a goal of mimicking natural infections as closely as possible. However, a major limitation of implementing animal models is how little is known about what aspects of a natural infection truly affect disease progression. In this study, we report important differences in the progression of bubonic plague in a comparison of the more commonly used s.c. route and the more biologically relevant i.d. route.
We observed that bacteria are able to colonize the host more rapidly (i.e., faster kinetics) after i.d. than after s.c. inoculations. This might be due to differences in the density and the anatomy of lymphatic vessels in each layer of the skin. The dermis is rich in terminal lymphatic vessels, which are absent in the epidermis and the s.c. space (28) . Terminal lymphatic vessels lack smooth muscle cells and a basal membrane. The absence of these two elements increases the permeability of the vessels and makes them able to readily take up lymph and antigen (29) . This is exemplified by experiments in which dyes to map lymphatic vessels for tumor detection are detected faster in LNs after i.d. injection than in LNs after s.c. injection (30) . Unlike terminal lymphatic vessels, collecting lymphatics possess circumferential smooth muscle cells, are surrounded by a basement membrane, and are found in the s.c. layer of the skin (29) . The presence of smooth muscle cells and a basement membrane restricts the access of particles into the lumen of the lymphatic vessels and makes them less efficient in antigen uptake. In addition to lymphatic vessel physiology, it also has been suggested that the dermis is subject to high fluid pressures (28) . High pressures are important to drain fluid from the dermis to prevent edema and could also contribute to more efficient movement of Y. pestis to the LNs. This is especially true if, as we have previously suggested, Y. pestis travels to LNs freely with the flow of lymph (11) . Thus, this suggests that Y. pestis cannot access LNs through lymphatic vessels as easily when deposited in the s.c. space as when deposited into the dermis.
Intriguingly, we found that while the kinetics of infection are faster when Y. pestis is delivered into the dermis, some mice survive after i.d. inoculation but none after s.c. inoculation. This is most evident when low inocula are used. Most mice survived after inoculation of 7 CFU in the dermis and none after inoculation of a very similar dose (24 CFU) in the s.c. space. In our bottleneck study, we found that a small percentage of i.d. inoculated mice did not have any detectable bacteria in their LNs and spleens (11) . This suggested that the bottleneck could be highly efficient. It would be expected that the effects of a barrier (i.e., bottleneck) that limits dissemination to LNs are stronger when few bacteria are inoculated and weaker when larger numbers of bacteria are used. Consequently, all mice inoculated i.d. with a high inoculum (ϳ710 CFU) died, and most of the mice inoculated with a low inoculum (ϳ7 CFU) survived. Unlike the dermis, the s.c. layer of the skin possesses a very limited number of resident cells of the immune response (31) . In addition, the s.c. space is less vascularized than the dermis, and, thus, access to it by infiltrating immune cells might be less efficient (3, 31) . We speculate that a less efficient immune response could allow for local bacterial replication in the s.c. space favoring subsequent dissemination that is not influenced by an initial low dose.
The use of the i.d. model also demonstrated a more pronounced attenuation of the ⌬rovA mutant than previously observed using the s.c. model (20) . We speculate that this indicates a role for RovA-regulated genes in bacterial adaptation to the immune response of the dermis. While many aspects of the anatomy and physiology of the different layers of the skin are understood, their effects on the immune response to pathogens are not clear. However, studies in the cancer and vaccine development fields have shed some light on the effects of the immune responses of the different layers of the skin. Bonnotte and collaborators found that injection of a tumorigenic cell line results in tumor formation after s.c. but not i.d. injection in rats (32) . In another study, injection of a virus-like particle to test its immunogenicity showed more LN involvement and cellular response after i.d. injection than with s.c. delivery (33) . In addition, results favoring the use of i.d. over s.c. inoculations have been reported in experiments using an HIV-1 antigen in vaccine development against this virus (34) . Much less work has been done comparing routes of inoculation during cutaneous infections caused by vector-borne pathogens. One exception is the work done with Leishmania parasites in which the use of an i.d. route appeared to recreate disease progression more accurately than an s.c. route (7) . Together these studies indicate that the different layers of the skin differ considerably in the immune responses they can elicit. Differences in the immune response might account for the different phenotypes that the ⌬rovA strain shows after inoculation in each layer of the skin. Thus, in the s.c. space, RovA seems to be primarily important as a regulator of a single locus (psa). In contrast, in the dermis, the more severe attenuation of the ⌬rovA strain suggests that RovA regulates additional genes that play a relevant role during infection. Our experiments highlight the importance of using a biologically relevant model when determining the levels of attenuation of deletion mutants.
Lastly, while we support the use of an i.d. model of infection, we think s.c. inoculations can be useful as an experimental strategy to answer some questions regarding bacterium-host interactions. For example, we used the s.c. model as an experimental strategy to test for the reduction of tagged strains during late stages of infection (dissemination from LNs to systemic sites). This reduction had already been observed in the i.d. route, but quantification was challenging. The s.c. inoculation route resulted in enough tagged strains in the LNs to determine whether any of them were lost as disease progressed to a systemic organ. With this strategy, we confirmed that only a fraction of the tagged strains present in the LNs predominate in the spleen. This is in agreement with our definition of a bottleneck. While the exact location of this bottleneck is unknown, we think it might result from as yet uncovered immune processes in the LNs or blood.
For vector-borne infections, including bubonic plague, well-established models might need to be revisited and modifications to these models might need to be considered to optimize our ability to make biologically relevant observations. As we established, in addition to being more biologically relevant, the observations made using these approaches differ considerably from those obtained by more conventional alternatives. Overall, we propose that approaches that use i.d. inoculations (along with fully virulent strains) should be given priority when studying the pathogenesis of Y. pestis.
